SCHEMBL18995993

SCHEMBL18995993

C=Cc1ccc(COc2c(C)cc(Oc3c(C)cc(C)cc3C)cc2C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
CASP3 P42574 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
MAOB P27338 4/20 0.36
MAOA P21397 2/20 0.36
PTPN1 P18031 1/20 0.35
MAPT P10636 2/20 0.34
HIF1A Q16665 1/20 0.34
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26011755 0.93 NPC1 (0.38) NPC1RAB9ACASP3SMN1; SMN2SENP8
SCHEMBL25559299 0.91 SMN1; SMN2 (0.39) NPC1RAB9ACASP3SMN1; SMN2SENP8
SCHEMBL15702903 0.90 FFAR1 (0.41) NPC1RAB9ACASP3SMN1; SMN2SENP8
SCHEMBL14749885 0.88 MAPT (0.33) NPC1RAB9ACASP3SMN1; SMN2SENP8
SCHEMBL14749976 0.84 MAOB (0.42) NPC1RAB9ACASP3SMN1; SMN2SENP8
SCHEMBL19077749 0.84 MAPT (0.35) SMN1; SMN2MAPTHIF1ACHRNB2CHRNB4
SCHEMBL19860053 0.82 MAPT (0.34) NPC1RAB9ACASP3SMN1; SMN2SENP8
SCHEMBL19077748 0.81 MAPT (0.35) SMN1; SMN2PTPN1MAPTHIF1ACHRNB2
SCHEMBL12299710 0.80 ALDH1A1 (0.34) NPC1RAB9ACASP3SMN1; SMN2SENP8
SCHEMBL22858574 0.77 GCGR (0.42) NPC1RAB9ACASP3SMN1; SMN2SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174957-A1 POLYPHENYLENE ETHER OLIGOMER AND HIGH-FREQUENCY COPPER CLAD LAMINATE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174957-A1 POLYPHENYLENE ETHER OLIGOMER AND HIGH-FREQUENCY COPPER CLAD LAMINATE CPNE4, COPE, HLA-DRB1 NPC1 2245/4885RAB9A 2060/4885CASP3 3251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.